In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify marijuana to be a Schedule III drug. This rescheduling will realize that cannabis has legitimate healthcare applications and may help open up the doorway to exploration on other potential cure utiliz